Cargando…
Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
Vascular endothelial growth factor (VEGF) is a potent promoter of angiogenesis involved in a wide variety of physiologic processes. Intravitreal injections targeting VEGF have transformed the treatment of neovascular retinal diseases. Currently, there are four anti-VEGF agents in use: bevacizumab, r...
Autores principales: | Agrawal, Shivi, Joshi, Malav, Christoforidis, John B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836427/ https://www.ncbi.nlm.nih.gov/pubmed/24307762 http://dx.doi.org/10.1155/2013/943409 |
Ejemplares similares
-
Systemic Treatments for Noninfectious Vitreous Inflammation
por: Jiang, Angela, et al.
Publicado: (2013) -
Drug Delivery Implants in the Treatment of Vitreous Inflammation
por: Wang, Jillian, et al.
Publicado: (2013) -
Intravitreal Devices for the Treatment of Vitreous Inflammation
por: Christoforidis, John B., et al.
Publicado: (2012) -
Inflammatory Mechanisms of Idiopathic Epiretinal Membrane Formation
por: Joshi, Malav, et al.
Publicado: (2013) -
Systemic Treatment of Vitreous Inflammation
por: Christoforidis, John B., et al.
Publicado: (2012)